ClinicalTrials.gg
Not yet recruitingNCT07256327SPDUpdated Aug 19, 2026

Chiropractic for Kids With Sensory Processing Challenges

An observational study in Sensory Processing Disorder, sponsored by Life University. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Life University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
17
Ages
5 Years to 12 Years
Sex
All
01

Study summary

The main aim of this pilot observational study is to investigate the feasibility of implementing our novel assessment battery in tandem with normal and customary chiropractic care in a practice-based setting using a pediatric population with parent-reported sensory processing disorder (SPD). The secondary aim is to assess potential changes in objective and subjective outcomes.

Read the detailed description

Up to 17 students with probable or definite parent-reported SPD as determined by the Short Sensory Profile (SSP) will be enrolled. The primary outcomes are 1) eligibility, 2) tolerability, 3) adherence, and 4) retention. The secondary aim is to assess the potential effects of subluxation-based pediatric chiropractic care on electrocardiography (ECG)-derived heart rate variability (HRV) and parent-reported outcomes (PROs). Results from this study will inform the feasibility of a larger study powered to assess the effectiveness of pediatric chiropractic care on clinical outcomes in a pediatric population with SPD.

02

Conditions studied

  • Sensory Processing Disorder

Keywords

  • Pediatrics
  • Chiropractic
  • Autonomic Nervous System
  • Pilot Projects
  • Sensation Disorders
  • Neurodevelopmental Disorders
03

In context

Sensation Disorders

87 studies on the registry are indexed under Sensation Disorders; 23 are open to participants now.

This study's planned enrollment of 17 is below the median of 58 across 25 observational studies indexed under Sensation Disorders.

Browse Sensation Disorders studies →

Lead sponsor

Life University is the lead sponsor of 29 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 5-12 years whose parents/caregivers identify the presence of symptoms associated with sensory processing disorder (SPD). A formal clinical diagnosis is not required for inclusion.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 5-12 years of age.
  • SSP total scores ≤154

Exclusion criteria

Exclusion Criteria:

  • A known heart condition, including pacemakers
  • Chiropractic care within the past 30 days
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
17 participants (estimated)
Patient registry
No

Groups and cohorts

  • Children (5-12) with SPD-Related Symptoms

    Children aged 5-12 years whose parents/caregivers identify the presence of symptoms associated with sensory processing disorder (SPD). A formal clinical diagnosis is not required for inclusion.

06

What researchers measure

Primary outcomes

  1. Proportion of students enrolled

    Number of students enrolled, divided by the total number of eligible students identified via the online screen. This assesses 'Enrollment'

    Time frame: From online screen submission to consent (up to 4 weeks)

  2. Proportion of completed assessment sessions

    The number of completed ECG sessions, divided by the total number of scheduled ECG sessions (excludes sessions scheduled after withdrawal). This assesses 'Compliance'

    Time frame: From enrollment to end of trial participation (up to 12 weeks)

  3. Proportion of students adhering to the care plan

    The number of students attending at least 90% of their scheduled chiropractic care sessions, divided by the total number of students enrolled (excludes sessions schedule after withdrawal). This assesses 'Adherence'.

    Time frame: From enrollment to the end of participation (up to 12 weeks)

  4. Proportion of students retained

    The number of participants attending the final ECG session, divided by the total number of students enrolled. This assesses 'Retention'.

    Time frame: From enrollment to the end of the 12 week study period.

Secondary outcomes

  1. Change in Heart Rate Variability (HRV)

    Change in resting-state heart rate variability (HRV) from baseline. Children will undertake 3 minutes of electrocardiography (ECG) while seated. ECG data will be used to derive HRV.

    Time frame: From enrollment to the end of participation (up to 12 weeks)

  2. Change in Short Sensory Profile (SSP) Scores

    Change in SSP scores from baseline. The SSP is a 38-item parent-report designed to assess a child's responsiveness to sensory stimuli including tactile sensitivity, taste/smell sensitivity, and visual/auditory sensitivity.

    Time frame: From enrollment to the end of participation (up to 12 weeks)

  3. Change in Pediatric Autonomic Symptom Scales (PASS) Scores

    Change in PASS scores from baseline. The PASS is an 80-item parent-report questionnaire designed to assess autonomic function in children across four main subscales: 1) mood, behavior, and emotion; 2) secretomotor/sensory integration; 3) urinary/gastrointestinal systems; 4) circulation, thermoregulation, sleep, and breathing.

    Time frame: From enrollment to the end of participation (up to 12 weeks)

07

Study locations

1 site
  • Well Adjusted Students
    Chippewa Falls, Wisconsin 54729, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified IPD necessary to reproduce results.

Supporting information: Analytic code

Time frame: (start date): within 1 year of study completion. (end date): indefinitely

Access criteria: IPD, metadata \& analytic code necessary to reproduce results will be made publicly accessible via a data repository

Data sharing details ↗ · figshare.com

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Dec 2026, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2025
First posted
Dec 1, 2025
StartEst.
Aug 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07256327
Lead sponsor
Life University
Responsible party
Tyson Perez, DC, PhD (PI, Life University) — Principal investigator
First posted
Dec 1, 2025
Start date
Aug 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Aug 19, 2026

Study contacts

Research Programs & Grants Administrator
Contact
angela.seckington@life.edu
678-331-4527
Tyson Perez, DC, PhD
principal investigator · Life University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion